Literature DB >> 12630021

Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities.

Emmanuel Andrès1, Jean Emmanuel Kurtz, Anne-Elisabeth Perrin, Francis Pflumio, Anne Ruellan, Bernard Goichot, Patrick Dufour, Jean-Frédéric Blicklé, Jean Marie Brogard, Jean-Louis Schlienger.   

Abstract

BACKGROUND/AIMS: Adult Still's disease is one of the febrile disorders of unknown etiology, characterized by high fever, transient cutaneous rash and leukocytosis. Liver dysfunction in adult Still's disease has been described in some case reports. The objective of this study was to analyze the pattern and the frequency of liver abnormalities in a monocenter series of adult Still's disease patients.
METHODOLOGY: Data of 17 patients with adult Still's disease (fulfilling Yamaguchi's diagnostic criteria) were retrospectively reviewed. These patients were followed in an Internal Medicine Department over a period of 7 years.
RESULTS: The median age was 27 years with a sex ratio M/F of 1.4. Fever was present in 100% of the cases and hepatomegaly occurred in 47% of the cases. Abnormalities in liver biochemistry, apparent in 76% of the subjects were characterized from moderate (elevation of transaminases between 2 and 5 N) (65%) to severe cytolysis (level of transaminases > 5 N) (12%), cholestasis (elevation of gamma GT and/or PAL) (65%), and increase in the level of LDH (35%). All of these symptoms disappeared either spontaneously or under treatment (83%), within a median period of 18 days.
CONCLUSIONS: This study confirms the high frequency of liver dysfunction in adult Still's disease patients. Although it is moderate and asymptomatic in most cases, severe cytolytic hepatitis has been described. This study especially puts forward the need for exploring the possibility of adult Still's disease in the presence of a fever and hepatic cytolysis.

Entities:  

Mesh:

Year:  2003        PMID: 12630021

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  16 in total

1.  Therapeutic responses and prognosis in adult-onset Still's disease.

Authors:  Hyoun-Ah Kim; Jun-Mo Sung; Chang-Hee Suh
Journal:  Rheumatol Int       Date:  2011-01-29       Impact factor: 2.631

2.  Clinical features and prognosis of adult-onset Still's disease: 75 cases from China.

Authors:  Zhenzhen Liu; Xiaoju Lv; Guangmin Tang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  Diagnosis and management of adult onset Still's disease.

Authors:  P Efthimiou; P K Paik; L Bielory
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

Review 4.  Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature.

Authors:  J-B Arlet; Thi Huong D Le; A Marinho; Z Amoura; B Wechsler; T Papo; J-C Piette
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

5.  Involvement of the liver in rheumatic diseases.

Authors:  Hiromasa Ohira; Kazumichi Abe; Atsushi Takahashi
Journal:  Clin J Gastroenterol       Date:  2011-11-26

6.  Adult Onset Still's Disease and Rocky Mountain Spotted Fever.

Authors:  Paul Persad; Rajendrakumar Patel; Niki Patel
Journal:  Case Rep Med       Date:  2010-08-09

Review 7.  Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.

Authors:  Apostolos Kontzias; Petros Efthimiou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Ten years of clinical experience with adult onset Still's disease: is the outcome improving?

Authors:  Sukhbir Singh Uppal; Moudhi Al-Mutairi; Sawsan Hayat; Mini Abraham; Anand Malaviya
Journal:  Clin Rheumatol       Date:  2006-11-04       Impact factor: 3.650

9.  Pseudo-angiocholitis revealing adult-onset Still's disease.

Authors:  Isabelle Marie; Philippe Ducrotté; Ghassan Riachi; Arnaud François; Hervé Levesque; Hubert Courtois
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.487

10.  Myositis, Vasculitis, Hepatic Dysfunction in Adult-Onset Still's Disease.

Authors:  Hidekatsu Yanai; Nobuyuki Furutani; Hiroshi Yoshida; Norio Tada
Journal:  Case Rep Med       Date:  2009-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.